Icatibant 30mg/3ml solution for injection pre-filled syringes
NHS hospitals in England used £21,686,205 of indicative cost of Icatibant 30mg/3ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 7.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Icatibant 30mg/3ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Icatibant 30mg/3ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hospitals Plymouth Nhs Trust | £1,983,690 |
| Barts Health Nhs Trust | £1,930,680 |
| University Hospital Southampton Nhs Ft | £1,555,425 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,413,135 |
| Manchester University Nhs Ft | £1,363,845 |
| Leeds Teaching Hpls Nhs Trust | £1,337,805 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,122,975 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,109,025 |
| North Bristol Nhs Trust | £1,049,040 |
| Oxford University Hospitals Nhs Ft | £1,032,300 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.